188 related articles for article (PubMed ID: 18438663)
1. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20.
Caberg JH; Hubert P; Herman L; Herfs M; Roncarati P; Boniver J; Delvenne P
Cancer Immunol Immunother; 2009 Jan; 58(1):39-47. PubMed ID: 18438663
[TBL] [Abstract][Full Text] [Related]
2. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
3. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
4. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
5. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.
Guess JC; McCance DJ
J Virol; 2005 Dec; 79(23):14852-62. PubMed ID: 16282485
[TBL] [Abstract][Full Text] [Related]
6. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
7. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
[TBL] [Abstract][Full Text] [Related]
8. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
[TBL] [Abstract][Full Text] [Related]
11. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
12. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY
PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154
[TBL] [Abstract][Full Text] [Related]
13. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
15. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20.
Yao T; Lin Z
Biochim Biophys Acta; 2012 Feb; 1822(2):248-60. PubMed ID: 22001440
[TBL] [Abstract][Full Text] [Related]
17. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells.
Le Poole IC; ElMasri WM; Denman CJ; Kroll TM; Bommiasamy H; Lyons Eiben G; Kast WM
Cancer Immunol Immunother; 2008 Jun; 57(6):789-97. PubMed ID: 18004565
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
Zhao J; Zhu J; Guo J; Zhu T; Zhong J; Liu M; Ruan Y; Liao S; Li F
J Med Virol; 2020 Mar; 92(3):372-381. PubMed ID: 31670402
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]